• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

The Rally in Johnson & Johnson Looks Like it has Run Its Course

Let's check out the charts.
By BRUCE KAMICH
Mar 15, 2019 | 12:09 PM EDT
Stocks quotes in this article: JNJ, FB

In Thursday night's Mad Money program, Jim Cramer told viewers that there are still plenty of opportunities for individuals to buy individual stocks. Before you capitalize on those opportunities, however, you must know the risks. Cramer identified five risks that investors need to consider.

One risk was with Johnson & Johnson (JNJ) and Facebook (FB) , two long-time favorites of Jim. He said JNJ is a fabulous company, but with the recent $29 million verdict against it and thousands of other lawsuits pending, it's enough to rattle even the most steadfast investors.

Let's check out the charts.

In this Japanese candlestick chart of JNJ, below, we can see the price action of the last six months (only looking at six months of candles allows us to see the patterns better). Prices are above the rising 200-day moving average line and the bullish 50-day moving average line, but we know that moving averages are lagging indicators.

Trading volume was heavy back in December on the cancer-talc news and it has dried up (no pun intended) over the past three months. A rally on light volume is always suspect as it shows a lack of commitment by the bulls.

The daily On-Balance-Volume (OBV) line goes flat in late December through most of January - the best time to have bought JNJ for a trade to the upside. The OBV line does creep higher from late January but it is still below the best levels since back in November.

If we look back at November we can see that the $140-$149 area was a resistance zone and longs who were surprised by the December break are probably anxious to "get even" if JNJ can push just a little higher. The middle of the long red candle from December can also act as a resistance area.

The 12-day price momentum study in the bottom panel shows that the rate of the advance has slowed from February into March - another sign that signals that the bulls are losing their grip, so to speak.

In this weekly bar chart of JNJ, below, we can see that prices have made very little upside progress the past two years. Prices are above the rising 40-week moving average line but a small decline will test/break that trend.

The weekly OBV line shows a decline from the middle of 2017 and suggests a long period of distribution (selling) of JNJ shares. The Moving Average Convergence Divergence (MACD) oscillator shows lower highs the past three years and is now right on the zero line.

If prices continue to rally then we should get a buy signal here but if prices roll over soon a buy signal won't happen.

In this Point and Figure chart of JNJ, below, we can see an upside price target of $168 but we can also see where the heavy volume has been traded (left scale).

Key support is in the mid-$120's and if that support gives way then JNJ has made a major top.

Bottom line strategy: If you are long JNJ I would suggest raising sell stops to a close below $135.

(Johnson & Johnson and Facebook are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells JNJ or FB? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Pharmaceuticals

More from Investing

When it Comes Time to Sell, Will You Act or Will You Freeze?

James "Rev Shark" DePorre
Jan 16, 2021 10:00 AM EST

Why don't more people embrace the ease and power of selling stocks? Why do they freeze and do nothing as losses build?

Cybersecurity Stocks that Lagged in 2020 Could Get Boost from SolarWinds Hack

Eric Jhonsa
Jan 16, 2021 8:00 AM EST

The hack stands to drive an uptick in corporate and government spending to protect both on-premise and cloud assets.

Hungry Traders and Stock Opportunities Aren't Likely to Go Away Soon

James "Rev Shark" DePorre
Jan 15, 2021 4:40 PM EST

It doesn't take much time for stocks with strong momentum to reset and continue on their way.

At What Price Is Ballard Power Systems a Buy?

Bruce Kamich
Jan 15, 2021 3:09 PM EST

Let's check out the latest charts of BLDP.

United Parcel Service Is Testing Key Support

Bruce Kamich
Jan 15, 2021 2:30 PM EST

A look at the charts of UPS.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • 08:35 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 1/13/2021

    Lower highs... SPX (Long-Term View) The 1/8/2...
  • 08:07 AM EST GARY BERMAN

    Tuesday Morning Fibocall for 1/12/2021

    Watch if the recent trend of lower highs continues...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login